Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 383 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 183 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 1, wobei auf jede offiziell registrierte Infektion etwa 312 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 6.527 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 15 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 23.10.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
High-pressure macromolecular crystallography as a tool for studying protein flexibility. 01.11.2026
Pooled intravenous immunoglobulins exhibit broad binding and Fc-mediated activity against diverse SARS-CoV-2 variants 22.10.2026
SARS-CoV-2 spike protein enhances HBV replication via autophagy and aggravates inflammation in CHB patients with liver dysfunction 22.10.2026
Immunogenicity of Heterologous SARS-CoV-2 PHH-1V Protein Booster vaccination in People with Immunocompromising Conditions 22.10.2026
Prevalence of alpha-synuclein seeding activity in the Olfactory Mucosa following SARS-CoV-2 infection:results from a pilot study 22.10.2026
Impact of SARS-CoV-2 vaccination on cancer trends:a nationwide interrupted time series study 22.10.2026
LOng COvid Multidisciplinary consortium:Optimising Treatments and servIces acrOss the NHS (LOCOMOTION) - COV-LT2-0016 22.10.2026
Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19:providing the evidence base for health care services (CONVALESCENCE) - COV-LT-0009 22.10.2026
REmote Diet Intervention to REduce long Covid symptoms Trial (ReDIRECT) - COV-LT2-0059 22.10.2026
Cognitive Impairment in Long COVID:PhEnotyping and RehabilitatiOn (CICERO) - COV-LT2-0014 22.10.2026
Symptoms, Trajectory, Inequalities and Management:Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways (STIMULATE-ICP) - COV-LT2-0043 22.10.2026
The immunologic and virologic determinants of long COVID – COV-LT2-0041 22.10.2026
Long Covid Personalised Self-managemenT support – co-design and EvaluatioN (LISTEN) - COV-LT2-0009 22.10.2026
HypErpolarised Xenon Magnetic Resonance PuLmonary ImAging In PatieNts with Long-COVID (EXPLAIN) - COV-LT2-0049 22.10.2026
Using activity tracking and just-In-time messaging to improve adaptive pacing:A pragmatic randomised control trial – COV-LT2-0010 22.10.2026
Percutaneous auricular nerve stimulation for treating post-COVID fatigue (PAuSing-pCF) - COV-LT2-0022 22.10.2026
Immune analysis of long covid to inform rational choices in diagnostic testing and therapeutics – Working out the Immunology of Long COvid (WILCO) - COV-LT2-0027 22.10.2026
Understanding and using family experiences of managing Long Covid to support self care and timely access to services – COV-LT2-0005 22.10.2026
Impact of COVID-19 vaccination on preventing long COVID:a population-based cohort study using linked NHS data – COV-LT2-0006 22.10.2026
Non-hospitalised Children & young people (CYP) with Long Covid (CLoCk) - COV-LT-0022 22.10.2026
Therapies for Long COVID in non-hospitalised individuals:From symptoms, patient-reported outcomes and immunology to targeted therapies (TLC) - COV-LT-0013 22.10.2026
Development of a robust T cell assay to retrospectively diagnose SARS-CoV-2 infection and T cell cytokine release assay as diagnostic and monitoring assay in Long COVID patients – COV-LT2-0004 22.10.2026
Real-time Assessment of Community Transmission-Long COVID (REACT-LC) - COV-LT-0040 22.10.2026
Exploring <em>Psidium guajava </em>L. Leaf Fractions as a Sustainable Source of Antiviral Compounds for the Inhibition of SARS-CoV-2 Spike–ACE2 Interaction (Wuhan and Omicron) and 3CLpro Activity 22.10.2026
Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection 22.10.2026
Comparative Analysis of SARS-CoV-2 Immune Memory in Vaccinated and Hybrid individuals Two Years Post-Exposure 22.10.2026
An interpretable machine learning model integrating mucosal and cellular immunity to predict SARS-CoV-2 reinfection:a multicenter cohort study 22.10.2026
Case Report:Crying-triggered pallid and hypotonic episodes in a 6-week-old infant with SARS-CoV-2 infection—a diagnostic dilemma 22.10.2026
A novel model demonstrating that human immune cells promote multiorgan SARS-CoV-2 dissemination and human T cells limit anti-viral innate immunity 22.10.2026
Snail restricts SARS-CoV-2 entry by limiting ACE2 expression as part of broader remodelling of epithelial determinants of viral tropism 22.10.2026
PERAN GERAKAN SOSIAL ENDSARS DALAM PEMBUBARAN SARS DI NIGERIA TAHUN 2017-2020 22.10.2026
Performance Analysis of CNN and LSTM for SARS-CoV-2 Detection Based on Genomic Sequence Data 22.10.2026
Transfer Learning CNN for BRCA1 Gene Variant Classification Using a SARS-CoV-2 Detection Architecture 22.10.2026
The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication 22.10.2026
Prolonged Active SARS-CoV-2 Infection in a Patient With Chronic Lymphocytic Leukemia on Venetoclax 21.10.2026
INTERAÇÃO ENTRE PLAQUETAS E NEUTRÓFILOS NA IMUNOTROMBOSE ASSOCIADA À INFECÇÃO POR SARS-COV-2:UMA REVISÃO SISTEMÁTICA 21.10.2026
SARS-CoV-2 infection detection efficiency in Denmark before major vaccine impacts 21.10.2026
Susceptibility of human neural stem cells to SARS-CoV-2:Entry mechanisms and glycocalyx influence 21.10.2026
SARS-CoV-2 Seroprevalence and Antibody Dynamics in The Gambia During the Transition from Pandemic to Endemic Circulation – 2022 and 2023 21.10.2026
Crystal structures of SARS-CoV-2 main protease and its complex with PBI-0451 21.10.2026
Protective Effect of COVID-19 Vaccination on Post-Infection Visuospatial Deficits. 20.10.2026
Pandemic Politics:Developing Vaccines in Canada's Anti-vax Heartland. 20.10.2026
Bridging spatial scales in respiratory viral infection. 20.10.2026
Applying normalized p-control charts for early detection of local COVID-19 outbreaks. 20.10.2026
Jet-injected combinational adjuvants potentiate naked mRNA vaccines for protection against respiratory viral infections in mice. 20.10.2026
Obstructive sleep apnea is frequent in patients with Long COVID fatigue but is not significantly associated with alterations of quality of life and cognition. 20.10.2026
Nationwide survey of testing practices for respiratory viruses in Australia in the post COVID-19 pandemic era. 20.10.2026
Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026
Binding roles of major components and new inhibitor from Andrographis paniculata targeting SARS-CoV-2 main protease using molecular dynamics simulations, density functional theory, and in vitro study. 19.10.2026
SARS-CoV2-induced Schnitzler syndrome, inflammatory flare and successful treatment by anakinra during pregnancy:a case report. 19.10.2026
Post-Vaccination Chemosensory Dysfunction:Changes Following SARS-CoV-2 Vaccination in a Global Study. 19.10.2026
Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence. 19.10.2026
Kommentar 4. 19.10.2026
Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026:a cross-sectional study. 19.10.2026
Effect of telemedicine-delivered lifestyle interventions in older adults during the COVID-19 pandemic:a nationwide two-arm randomized trial (PROACTIVE-19). 19.10.2026
Effectiveness of physical, psychological, and alternative interventions for post-COVID-19 condition:a systematic review. 19.10.2026
Evaluating Classifier Derivation and Validation Beyond the Receiver Operating Characteristic Curve. 19.10.2026
Multiplexed Nucleic Acid Detection Using Sequence-Specific Cleavage Mediated by Repair Endonucleases. 19.10.2026
Transcription Regulatory Sequences in Coronaviruses:Mechanistic Foundations for Antivirals and Vaccines. 19.10.2026
Cerebrospinal fluid positive for SARS-CoV-2 associated with neurological manifestations and proteome alterations in a multiple myeloma patient. 19.10.2026
RSV, influenza, and COVID-19 in hospitalized children:A comparative analysis of the 2025/2026 epidemic season in Poland. 17.10.2026
The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026
Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026
Scaling of SARS-CoV-2 Genomic Divergence with Cumulative COVID-19 Infections. 15.10.2026
Long-Term Corneal Nerve and Ocular Surface Findings After COVID-19 Requiring Hospitalisation:An Observational Follow-Up Study. 14.10.2026
SARS-CoV-2 nucleocapsid protein hijacks host transcription by targeting eEF1A1. 14.10.2026
SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026
Error correction of SARS-CoV-2 genomic sequences using a phylogenetic prior 09.10.2026
Epidemiology and virological characteristics of the emerging SARS-CoV-2 variant PJ.2.1 08.10.2026
Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026
Disseminated BCG disease and recurrent pulmonary infections in a child with trisomy 21 carrying a novel BACH2 variant of uncertain significance:a 5-year case report. 05.10.2026
Association between air pollution and postacute sequelae of SARS-CoV-2. 01.10.2026
Heparan Sulfate Oligosaccharides Modulate SARS-CoV-2 Spike-Host Recognition. 01.10.2026
Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2. 01.10.2026
Permissive versus conventional weaning from venovenous ECMO in patients with ARDS:a retrospective cohort study. 29.09.2026
Mechanochemical Decoupling of ATP Hydrolysis and RNA Translocation in SARS-CoV‑2 nsp13 by the L405D Mutation 29.09.2026
The other immune landscape of SARS-CoV-2 evolution. 28.09.2026
Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026
N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection 17.09.2026
Healthy vaccinee effect by study design. 16.09.2026
Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026
Antibody evasion and receptor binding of SARS-CoV-2 RW.1.1 14.09.2026
Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026
Gut microbial allies and adversaries in SARS-CoV-2 infection. 10.09.2026
Antagonism of stress granules is key to SARS-CoV-2 infection and pathogenesis. 08.09.2026
Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies 07.09.2026
Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies. 07.09.2026
Immunity interrupted:Links between SARS-CoV-2 and the tripledemic of 2022. 30.08.2026
A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026
Scarless SARS-CoV-2 Genome Engineering and Variant Analysis 24.08.2026
Antibody-mediated SARS-CoV-2 entry and conformational regulation. 21.08.2026
The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026
Advances on Sensors and Diagnostics of SARS-CoV-2 Biomarkers. 01.08.2026
Prevalence of SARS-COV-2 infection, Relationship between SARS-CoV-2 and HIV among Sex Workers in Cotonou. 01.08.2026
Exploration of Nirmatrelvir Derivatives as Optimized SARS-CoV-2 Antivirals. 01.08.2026
Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers. 28.07.2026
SARS-CoV-2 resistance pathways to EDP-235. 27.07.2026
Acceptability and uptake of COVID-19 vaccines among pregnant and lactating women seeking services at a tertiary public hospital in Kampala, Uganda. 25.07.2026
Socioeconomic transitions and the spatial dynamics of syphilis transmission in urbanizing China. 24.07.2026
Quellen: PubMed, Europe PMC & CrossRef
Wie verbreitet ist das Coronavirus aktuell in Bayern? Das zeigen aktuelle Abwasser-Daten - Augsburger Allgemeine 23.10.2026
Long Covid: Diese Veränderung im Mikrobiom der Lunge deutet auf langfristige Corona-Folgen hin - WELT 23.10.2026
Erkältung: Die nächste Infektionswelle rollt an – wer sich jetzt unbedingt schützen sollte - WELT 23.10.2026
FPÖ: Haben Covid-U-Ausschuss „nicht vergessen“ - ORF 23.10.2026
Christina Applegate: MS-Fehldiagnose – steckt Long Covid oder ME/CFS dahinter? - Film plus Kritik 22.10.2026
Marburg im Zentrum der Forschung zu Long COVID und ME/CFS / Internationales Symposium ... - Presseportal 22.10.2026
Covid-Untersuchung: Schwere Versäumnisse in britischen Pflegeheimen - FAZ 21.10.2026
Fatigue: „Ist die Stressreaktion verändert, gilt das häufig auch für das Immunsystem“ - WELT 21.10.2026
Wenn jeder Schritt zu viel ist: Leben mit ME/CFS und Long Covid - SWR 20.10.2026
Aktuell keine Off-Label-Kandidaten gegen Long COVID in der Bewertung - AerzteZeitung.de 20.10.2026
Postinfektiöses Syndrom: Auskurieren und Impfen senken das Risiko für Spätfolgen einer Infektion - Apotheken Umschau 19.10.2026
Online-Reihe zu Post-Covid - Mittelhessen 19.10.2026
Zwei Jahre fast nur Liegen: So kämpft Annabelle gegen ME/CFS - ZDF 18.10.2026
Long Covid: Annabelle kämpft gegen ME/CFS - ZDF 18.10.2026
Nicht nur Patienten schuld: Warum so wenige gegen Grippe und Covid-19 geimpft sind - Gesundheit - SZ.de - SZ.de 14.10.2026
Grippeschutz- und COVID-19-Impfaktionen in Salzgitter - Stadt Salzgitter 09.10.2026
Long Covid und Co.: Leopoldina zählt auf, wo es bei Erforschung und Versorgung hapert - MDR.de 05.10.2026
Long-COVID besser verstehen und Versorgungslücken schließen: Stellungnahme zu postinfektiösen Erkrankungen - Nationale Akademie der Wissenschaften Leopoldina 01.10.2026
Corona 2026: Aktuelle Symptome und Varianten - was Betroffene wissen sollten - NDR.de 01.10.2026
Nicht nur Long Covid. Es gibt die Symptome auch nach grippalen Infekten - MDR.de 29.09.2026
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.